Literature DB >> 16213744

Pituitary radiotherapy: current controversies.

Neil J L Gittoes1.   

Abstract

External beam radiotherapy has been used extensively in the management of patients with pituitary disease. However, in view of advances in the techniques of radiotherapy planning and administration, neurosurgery and pharmacological manipulation of the pituitary, there are a growing number of questions and controversies surrounding the current and future use of pituitary radiotherapy in the management of pituitary disease.

Entities:  

Mesh:

Year:  2005        PMID: 16213744     DOI: 10.1016/j.tem.2005.09.008

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  3 in total

Review 1.  Mortality following pituitary radiotherapy.

Authors:  John Ayuk; Paul M Stewart
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

2.  Triple jeopardy in the pituitary.

Authors:  Kian-Peng Goh; Hwei-Yee Lee; Raja C Rajasoorya
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

3.  Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.

Authors:  Jean Christophe Maiza; Delphine Vezzosi; Maria Matta; Florence Donadille; Florence Loubes-Lacroix; Maxime Cournot; Antoine Bennet; Philippe Caron
Journal:  Clin Endocrinol (Oxf)       Date:  2007-05-24       Impact factor: 3.478

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.